Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Autoimmunity Reviews, 2009
May 12 (UPI) -- U.S
The immediate next step is still choosing the right current therapy If dual-pathway research has you rethinking what comes after GLP-1 monotherapy, Prescription Options Beyond GLP-1 can help frame what is available now, what still belongs to the pipeline, and how to build a more realistic treatment strategy
Efficacy and safety of glp-1 receptor agonists and sglt-2 inhibitors in the treatment of diabetes mellitus and obesity in liver transplant recipients: a systematic review
US$ 23.40
US$ 24.92
US$ 22.18
US$ 20.88
